Undifferentiated Sarcoma — Variants & evidence

Undifferentiated Sarcoma — Variants & evidence · CancerIndex

Variants & evidence

Curated clinical evidence by variant and therapy

1 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.

civicCuratedShowing 1–1 of 1 evidence items (1 on this page mapped to a descendant entity) · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Cancer	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
NTRK1 Fusion1
(oncogenic)	Undifferentiated Pleomorphic Sarcoma	Oncogenic	C	Supports Oncogenicity	1	submitted	EID13059 Dufresne et al. identified a CCDC171::NTRK1 fusion by whole-exome RNA sequencing in one undifferentiated pleomorphic sarcoma from an ambispective cohort of NTRK-rearranged mesenchymal tumors. The fusi… (full text at CIViC) PMID 37054503 · Dufresne et al., 2023 · Open in CIViC	civic

Data updated 16 hours agoSource updated unknownsource: civic (CC0)

Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.